Important legislation that would prevent stripping antidepressants and immunosuppresants of their protected status
Because patients that rely on antidepressants and immunosuppressant medications may react differently to each treatment, access to the full range of effective medications is a crucial component of successful care.
Let’s protect those who have to take antidepressants and immunosuppressants from having their medications stripped from being protected.
The Senate is now considering important legislation that would cement today’s protections by codifying the current provision under Medicare Part D that ensures open access to beneficiaries in need of potentially lifesaving antidepressants, immuno-suppressants, antipsychotics, anticonvulsants, oncology, and HIV/AIDS drugs.
In March of this year, Senators Charles Grassley (R-IA) and Sherrod Brown (D-OH) introduced the Medicare Formulary Improvement Act (S.648). Unfortunately, this effort is currently stalled in the Senate pending a necessary “scoring” of the bill’s budgetary impact by the Congressional Budget Office (CBO). The bill’s sponsors, and we, believe that the bill will score at a cost of “zero,” but without the CBO’s analysis, Congress simply won’t allow the bill to move forward.Read More